mutations offered The truth that, as defined under, CLL therapy is predicated on the existence or absence of such mutations. The current consensus is that, other than clonal mutations, subclonal mutations having a variant allelic frequency starting from five to ten% (and so under the edge of detection by regular molecular strategies) is also claime